SC 13G
GALERA THERAPEUTICS, INC.
- Company
- Galera Therapeutics, Inc.
- Filed
- December 27, 2021
- Accession Number
- 0001104659-21-153570
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →